NCT02567149 2017-07-02
Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population.
University of Minnesota
Phase 2 Withdrawn
University of Minnesota
Brugmann University Hospital
AIDS Malignancy Consortium
National Cancer Institute (NCI)